All In MedTech

FDA Clearance Tracker · P010014

OXFORD(TM) MENISCAL UNICOMPARTMENTAL KNEE SYSTEM

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Apr 21, 2004 (this decision)Source: openFDAMethods & limitations

PMA

Decided

Apr 21, 2004

Approved

Time to decision

1,147 days

Received Mar 1, 2001. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P010014
Device name
OXFORD(TM) MENISCAL UNICOMPARTMENTAL KNEE SYSTEM
Applicant location
Warsaw, IN
Received
Mar 1, 2001
Decided
Apr 21, 2004
Decision
Approved
Supplements
108 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code NRA

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE OXFORD MENISCAL UNICOMPARTMENTAL KNEE SYSTEM (PHASE 3). THE DEVICE IS INDICATED FOR USE IN PATIENTS WITH OSTEOARTHRITIS OR AVASCULAR NECROSIS LIMITED TO THE MEDIAL COMPARTMENT OF THE KNEE AND INTENDED TO BE IMPLANTED WITH BONE CEMENT.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code NRA. The earliest in FDA's data is P910016, decided Oct 30, 1992.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Biomet Manufacturing Corp

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.